Post-Market Safety Surveillance in China
Post-Market Safety Surveillance in China Post-Market Safety Surveillance in China: Regulatory Expectations and Practices Introduction Post-market safety surveillance is an essential part of the life cycle of medicinal products, ensuring that adverse events are identified, evaluated, and managed after approval. In China, the National Medical Products Administration (NMPA) has significantly strengthened its pharmacovigilance (PV) framework…